MBODY AI LTD
MBAINASDAQ🏆 #4388 by market capUS Equity
$487.34▲ $37.57 (+7.71%)
Simulated priceTrack MBAI
Get earnings, price moves & breaking news on Telegram
24h▲ 7.7%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$57M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
64
Fair
No chart data available for MBAI.
Trading Snapshot
- Day Range
- $483.37 – $496.99
- 52-Week Range
- $3.88 – $27.44
- Volume
- $2.71B
- Avg Volume
- $3.41B
- Shares Outstanding
- 7.0M
- Next Earnings
- Dec 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $15M
- Last Q Revenue
- $4M
- P/E Ratio
- 6.7
- P/S Ratio
- —
- EPS (TTM)
- $1.56
- Dividend Yield
- —
Why Investors Own MBAI
- ✓High-growth profile — revenue up +37.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 33% gross margin and 17% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MBODY AI LTD
MBAIFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$2M▼ −90.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$46K▼ −99.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$14K▲ +$122K YoY
StockOtter · stockotter.spaceAbout MBODY AI LTD
Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100
Analyst Price Target
ⓘAverage Target
$555.78
▲ +14.0% Upside
High Target$673.82
Low Target$500.00
Based on 28 analysts
Latest News & Updates
🚀
Reuters·2h ago
MBODY AI LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Barron’s·5h ago
Analysts lift MBAI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
MBODY AI LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.